MAP3K7 and obesity due to melanocortin 4 receptor deficiency: A recent study demonstrated that tamoxifen-inducible adipocyte-specific deletion of TAK1 in mice reduces obesity, potentially through diminishing the survival of adipocytes and induction of browning in white adipose tissue [30].